PHX.AX ASX
PharmX Technologies Limited
1W: -3.0%
1M: +9.1%
3M: -12.7%
YTD: -28.9%
A$0.10 ($0.07)
+0.00 (+0.00%)
Weekly Expected Move ±8.9%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$7M
+12.8% ▲
Gross Profit
$6M
+13.5% ▲
Operating Income
-$1M
-4.4% ▼
Net Income
-$264K
+85.1% ▲
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
$1M
-4.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2024 |
|---|---|
| Revenue | $7M |
| YoY Growth | +12.8% |
| Cost of Revenue | $1M |
| Gross Profit | $6M |
| Gross Margin | 81.4% |
| R&D Expenses | -$324K |
| SG&A Expenses | $5M |
| Operating Expenses | $7M |
| Operating Income | -$1M |
| Operating Margin | -19.4% |
| Interest Expense | $31K |
| Income Before Tax | $79K |
| Tax Expense | $343K |
| Net Income | -$264K |
| Net Margin | -3.6% |
| EPS (Diluted) | $0.00 |
| EBITDA | $1M |
| Shares Outstanding | 0 |